Abstract
Introduction

38
Visceral leishmaniasis (VL), also known as "Kala azar" is caused by the intracellular protozoan 39 Leishmania donovanii and is transmitted by the bite of infected phlebotomine sandflies. It has 40 been estimated that the annual global burden of VL is 500 000 new cases with more than 59 000 41 associated deaths (Den Boer et al., 2011) . The control of VL relies entirely on chemotherapy 42 due to lack of antileishmanial vaccines. In poor countries, however, the use of leishmanicidal 43 drugs is hampered by high costs, toxicity and the emergence of resistance (Sundar et al., 2007) .
44
In addition, the emergence of the Human Immunodeficiency virus/Acquired Immunodeficiency 45 disease (HIV/AIDS) has severely compromised the control of VL (Alvar et al., 2008) .
46
Therefore, there is an urgent need for the development of new leishmanial therapeutics.
47
The genus Salvia (sage) is the largest in the Lamiaceae family with over 900 species worldwide (Codd, 1985) . Salvia species are used in 50 folk medicine for the treatment of asthma, eczema, psoriasis and tuberculosis (Salimpour et al., 51 2011). In South Africa, Salvia species are used against fever, headache and digestive disorders 52 (Amabeoku et al., 2001) , and to treat sores (Auge et al., 2003) . A decoction of the roots is also 53 used in South Africa for the treatment of stomach ache and diarrhoea (Auge et al., 2003) . 
